Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Altucci

Showing results (21-30 of 358) with videos related to

Pageof 36
Sort By:
Epigenetics|December 3, 2019
DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatmentFederica Sarno, Angela Nebbioso, Lucia Altucci
Frontiers in Pharmacology|February 15, 2019
Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant PhenotypeVincenzo Carafa, Lucia Altucci, Angela Nebbioso
Experimental Cell Research|February 17, 2012
HDAC modulation and cell death in the clinicCarmela Dell'Aversana, Ilaria Lepore, Lucia Altucci
Molecular Cancer Therapeutics|May 17, 2008
Competitive or noncompetitive, that's the question: research toward histone deacetylase inhibitorsHong Su, Lucia Altucci, Qidong You
Epigenomics|November 30, 2011
Targeting epigenetic networks with polypharmacology: a new avenue to tackle cancerGianluigi Franci, Marco Miceli, Lucia Altucci
Methods in Molecular Biology (Clifton, N.J.)|November 10, 2016
MicroRNA Expression Profiling Using Agilent One-Color MicroarrayCarmela Dell'Aversana, Cristina Giorgio, Lucia Altucci
Frontiers in Oncology|August 15, 2020
Editorial: Sirtuinome Rewiring to Hijack Cancer Cell Behavior and Hamper Resistance to Anticancer InterventionStefano Falone, Athanassios Vassilopoulos, Lucia Altucci
The International Journal of Biochemistry & Cell Biology|June 6, 2007
Cancer therapy: new drugs are emerging based on molecular targeting but still many challengesLucia Altucci, Lodovico Balducci, Irmgard Irminger-Finger
Clinical Epigenetics|September 9, 2024
Epitranscriptomics and epigenetics: two sides of the same coin?Guglielmo Bove, Nunzio Del Gaudio, Lucia Altucci
The International Journal of Biochemistry & Cell Biology|March 15, 2018
HDAC inhibitors as epigenetic regulators for cancer immunotherapyMariarosaria Conte, Raffaele De Palma, Lucia Altucci
Pageof 36

Showing results (21-30 of 358) with videos related to

Sort By:
Pageof 36
Epigenetics|December 3, 2019
DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatmentFederica Sarno, Angela Nebbioso, Lucia Altucci
Frontiers in Pharmacology|February 15, 2019
Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant PhenotypeVincenzo Carafa, Lucia Altucci, Angela Nebbioso
Experimental Cell Research|February 17, 2012
HDAC modulation and cell death in the clinicCarmela Dell'Aversana, Ilaria Lepore, Lucia Altucci
Molecular Cancer Therapeutics|May 17, 2008
Competitive or noncompetitive, that's the question: research toward histone deacetylase inhibitorsHong Su, Lucia Altucci, Qidong You
Epigenomics|November 30, 2011
Targeting epigenetic networks with polypharmacology: a new avenue to tackle cancerGianluigi Franci, Marco Miceli, Lucia Altucci
Methods in Molecular Biology (Clifton, N.J.)|November 10, 2016
MicroRNA Expression Profiling Using Agilent One-Color MicroarrayCarmela Dell'Aversana, Cristina Giorgio, Lucia Altucci
Frontiers in Oncology|August 15, 2020
Editorial: Sirtuinome Rewiring to Hijack Cancer Cell Behavior and Hamper Resistance to Anticancer InterventionStefano Falone, Athanassios Vassilopoulos, Lucia Altucci
The International Journal of Biochemistry & Cell Biology|June 6, 2007
Cancer therapy: new drugs are emerging based on molecular targeting but still many challengesLucia Altucci, Lodovico Balducci, Irmgard Irminger-Finger
Clinical Epigenetics|September 9, 2024
Epitranscriptomics and epigenetics: two sides of the same coin?Guglielmo Bove, Nunzio Del Gaudio, Lucia Altucci
The International Journal of Biochemistry & Cell Biology|March 15, 2018
HDAC inhibitors as epigenetic regulators for cancer immunotherapyMariarosaria Conte, Raffaele De Palma, Lucia Altucci
Pageof 36